Drawing for REGENERCELL

USPTO serial 86452818

REGENERCELL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
TARCU, CATHERINE L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REGENERCELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Fang Xie

FANG XIE Greenberg Traurig Llp1 International PlBoston, MA 02110-2602UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Biological and chemical products for use by clinicians and veterinarians in regenerative medicine for medical and/or aesthetic purposes, namely, biological epithelial tissue and cells intended for subsequent implantation, skin grafts, biological preparations for the treatment of epithelial burns, wounds, and imperfections, biological or chemical reagents and preparations to be used together with the biological epithelial tissue and cells for medical purposes, namely, for treating epithelial burns, wounds, and imperfections; medicaments comprising suspensions of epithelial cells to assist with the regeneration of epithelium tissue such as skin, respiratory epithelium, intestinal epithelium, urothelium, and buccal mucosa; epithelium treatment and repair kits, comprised of prepared and suspended cellular medicaments to assist with the regeneration of epithelium tissue such as skin, respiratory epithelium, intestinal epithelium, urothelium, and buccal mucosa, as well as a drug preparation and delivery system featuring instruments, warming plates, delivery applicators and substances used for preparing, dissociating and suspending epithelial cells for delivery to the imperfect, wounded or damaged epithelium, to be used by clinicians and veterinarians to produce cellular preparations for the treatment of imperfect, wounded or damaged epithelium; bio-compatible medicated epithelial tissue and cell preparations for treatment by clinicians and veterinarians of epithelial imperfections, damages, diseases, and wounds, containing biomaterials, namely, enzymatically dissociated suspensions of epithelial cells and optionally additional factors for promoting cell growth, reproduction and/or differentiation; biological epithelial tissue, namely, reconstituted human epithelial tissues and cells for medical, clinical and/or aesthetic use by clinicians and veterinariansACTIVE—
010Medical system comprising medical apparatus in the nature of a drug preparation and delivery system featuring medical instruments, warming plates, delivery applicators and substances used for preparing, dissociating and suspending epithelial cells for delivery to the imperfect, wounded or damaged epithelium, for use by clinicians and veterinarians for preparing and delivering a medicament for the treatment of epithelial burns, wounds, imperfections and other damages; medical devices used by clinicians and veterinarians comprising an epithelial cell preparation, dissociation, suspension and delivery system featuring instruments, warming plates, delivery applicators and substances to promote the regeneration of epithelium tissue such as skin, respiratory epithelium, intestinal epithelium, urothelium, and buccal mucosa; epithelium treatment and repair kits comprised of a drug preparation and delivery system featuring medical instruments, warming plates, delivery applicators and substances used for preparing, dissociating and suspending epithelial cells for delivery to the imperfect, wounded or damaged epithelium by clinicians and veterinarians; all of the foregoing for non-invasive surgical purposes for use in connection with acute and chronic epithelial wounds and other imperfections by medical professionals and veterinarians in the field of regenerative medicineACTIVE—
041Education services in the field of regenerative medicine provided through classes, seminars and training programs; providing training to clinicians and veterinarians in the field of treatment of epithelial burns, wounds, imperfections and other damages, in particular regeneration of imperfect, wounded or damaged epithelium tissue such as skin, respiratory epithelium, intestinal epithelium, urothelium, and buccal mucosa; training of clinicians and veterinarians in using epithelium treatment and repair kits comprised of a drug preparation and delivery system featuring instruments, warming plates, delivery applicators and substances used for preparing, dissociating and suspending epithelial cells for delivery to the imperfect, wounded or damaged epitheliumACTIVE—
044Medical consulting services in the field of regenerative medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 5, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 5, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 16, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 15, 2019EX5GSOU EXTENSION 5 GRANTED—
Jan 15, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 5, 2019EXT5SOU EXTENSION 5 FILED—
Jan 5, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 7, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 5, 2018EX4GSOU EXTENSION 4 GRANTED—
Jul 5, 2018EXT4SOU EXTENSION 4 FILED—
Jul 5, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 6, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 4, 2018EX3GSOU EXTENSION 3 GRANTED—
Jan 4, 2018EXT3SOU EXTENSION 3 FILED—
Jan 4, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 7, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 5, 2017EX2GSOU EXTENSION 2 GRANTED—
Jul 5, 2017EXT2SOU EXTENSION 2 FILED—
Jul 5, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 5, 2017EX1GSOU EXTENSION 1 GRANTED—
Jan 5, 2017EXT1SOU EXTENSION 1 FILED—
Jan 5, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 5, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 24, 2016ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Dec 9, 2015ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 10, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 10, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 7, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 6, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 6, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Oct 6, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 6, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 6, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 29, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 29, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 22, 2015ALIEASSIGNED TO LIE—
Sep 8, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 6, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2015DOCKASSIGNED TO EXAMINER—
Nov 21, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Nov 20, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 17, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance